SEARCH RESULTS for assignee:"THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES"

Showing 1 to 20 of 91 results

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
14-Jun-2018

(X0) 1: PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS

(A1) 2: PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS

BROADT, TREVOR LANE

SHABAN, SAMIR HUSSEIN

XIE, YUEQING

ZHU, JIANWEI SEAN

MITRA, GEORGE

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

44279/447

14-Jun-2018

(X0) 1: COMPOSITIONS AND METHODS FOR DETECTION AND DISCRIMINATION OF EMERGING INFLUENZA VIRUS SUBTYPES

(A1) 2: COMPOSITIONS AND METHODS FOR DETECTION AND DISCRIMINATION OF EMERGING INFLUENZA VIRUS SUBTYPES

SHU, BO

LINDSTROM, STEPHEN

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

44333/857

08-Jun-2018

(X0) 1: METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE

(A1) 2: METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE

JACOBSON, KENNETH ALAN

TOTI, KIRAN SHAMBHU

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

46021/177

31-May-2018

(X0) 1: METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD

(A1) 2: METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD

GROS, ALENA

ROSENBERG, STEVEN A.

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

44537/564

31-May-2018

(X0) 1: POINT OF NEED TESTING DEVICE AND METHODS OF USE THEREOF

(A1) 2: POINT OF NEED TESTING DEVICE AND METHODS OF USE THEREOF

HENDERSON, WENDY A.

FOURIE, NICOLAAS H.

FERGUSON, ERIC G.

ABEY, SARAH K.

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES

44991/990

29-May-2018

(X0) 1: MONOMERIC GRIFFITHSIN TANDEMERS

(A1) 2: MONOMERIC GRIFFITHSIN TANDEMERS

(B2) 9: MONOMERIC GRIFFITHSIN TANDEMERS

O'KEEFE, BARRY R.

WLODAWER, ALEXANDER

MOULAEI, TINOUSH

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

38325/122

24-May-2018

(X0) 1: PREPARATION OF (R,R)-FENOTEROL AND (R,R)- OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE

(A1) 2: PREPARATION OF (R,R)-FENOTEROL AND (R,R)- OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE

WAINER, IRVING W.

ZHU, WEIZHONG

CHAKIR, KHALID

XIAO, RUI PING

ABERNETHY, DARRELL R.

BEIGI, FARIDEH M.

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

44692/122

23-May-2018

(X0) 1: DUAL SPECIFIC ANTI-CD22-ANTI-CD19 CHIMERIC ANTIGEN RECEPTORS

(A1) 2: DUAL SPECIFIC ANTI-CD22-ANTI-CD19 CHIMERIC ANTIGEN RECEPTORS

FRY, TERRY J.

MACKALL, CRYSTAL L.

ORENTAS, RIMAS J.

HASO, WALEED

QIN, HAIYING

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

45870/322

22-May-2018

(X0) 1: NOVEL INFLUENZA ANTIGENS AND ANTIBODIES

(A1) 2: NOVEL INFLUENZA ANTIGENS AND ANTIBODIES

(B2) 9: NOVEL INFLUENZA ANTIGENS AND ANTIBODIES

DONIS, RUBEN

STEVENS, JAMES

SHORE, DAVID

WAN, HONGQUAN

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

37835/371

22-May-2018

(X0) 1: OCTAPOD IRON OXIDE NANOPARTICLES AS HIGH PERFORMANCE T2 CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING

(A1) 2: OCTAPOD IRON OXIDE NANOPARTICLES AS HIGH PERFORMANCE T2 CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING

(B2) 9: OCTAPOD IRON OXIDE NANOPARTICLES AS HIGH PERFORMANCE T2 CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

39357/697

22-May-2018

(X0) 1: HUMAN ROTAVIRUS VACCINE STRAINS AND DIAGNOSTICS

(A1) 2: HUMAN ROTAVIRUS VACCINE STRAINS AND DIAGNOSTICS

(B2) 9: HUMAN ROTAVIRUS VACCINE STRAINS AND DIAGNOSTICS

JIANG, BAOMING

GLASS, ROGER I.

WANG, YUHUAN

GENTSCH, JON

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION

43527/460

22-May-2018

(X0) 1: NASAL AEROSOL DELIVERY SYSTEM

(A1) 2: NASAL AEROSOL DELIVERY SYSTEM

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION

45864/754

17-May-2018

(X0) 1: HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

(A1) 2: HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

HO, MITCHELL

FENG, MINGQIAN

DIMITROV, DIMITER S.

GAO, WEI

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

44595/394

07-May-2018

(X0) 1: Compositions and Methods for Inhibiting BMP

(A1) 2: Compositions and Methods for Inhibiting BMP

LEE, ARTHUR

MCKEW, JOHN C.

PATEL, PARESMA R.

SANDERSON, PHILIP E.

ZHENG, WEI

HUANG, XIULI

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

45717/361

03-May-2018

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

43585/255

03-May-2018

(X0) 1: IMAGING SYSTEMS AND METHODS USING FLUORESCENT NANODIAMONDS

(A1) 2: IMAGING SYSTEMS AND METHODS USING FLUORESCENT NANODIAMONDS

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

44110/382

02-May-2018

(X0) 1: PREVENTING OR TREATING VIRAL INFECTION BY INHIBITION OF THE HISTONE METHYLTRANSFERASE EZH1 OR EZH2

(A1) 2: PREVENTING OR TREATING VIRAL INFECTION BY INHIBITION OF THE HISTONE METHYLTRANSFERASE EZH1 OR EZH2

KRISTIE, THOMAS M.

ARBUCKLE, JESSE H.

PIERSON, TED C.

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

45684/540

01-May-2018

(X0) 1: MULTIVALENT MENINGOCOCCAL CONJUGATES AND METHODS FOR PREPARING CONJUGATES

(A1) 2: MULTIVALENT MENINGOCOCCAL CONJUGATES AND METHODS FOR PREPARING CONJUGATES

(B2) 9: MULTIVALENT MENINGOCOCCAL CONJUGATES AND METHODS FOR PREPARING CONJUGATES

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

39307/645

27-Apr-2018

(X0) 1: VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

(A1) 2: VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

VENDITTI, CHARLES P.

CHANDLER, RANDY

PAVAN, WILLIAM J.

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

45645/133

26-Apr-2018

(X0) 1: IMMUNOGENIC RSV POLYPEPTIDES

(A1) 2: IMMUNOGENIC RSV POLYPEPTIDES

KHURANA, SURENDER

GOLDING, HANA

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

43834/728